Commentary: Tolvaptan for Autosomal Dominant Polycystic Kidney Disease (ADPKD) - an update

Abstract Autosomal Dominant Polycystic Kidney Disease (ADPKD) affects up to 70 000 people in the UK and the most common inherited cause of end-stage kidney disease (ESKD). It is generally a late-onset multisystem disorder characterised by bilateral kidney cysts, liver cysts and an increased risk of...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Matt Gittus, Helen Haley, Tess Harris, Sarah Borrows, Neal Padmanabhan, Danny Gale, Roslyn Simms, Terri Williams, Aaron Acquaye, Alisa Wong, Melanie Chan, Eduardo Lee, Albert CM Ong
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	BMC 2025-02-01
Serie:	BMC Nephrology
Soggetti:	Autosomal Dominant polycystic kidney disease ADPKD Tolvaptan
Accesso online:	https://doi.org/10.1186/s12882-025-03960-4
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!